Filing Flows › ELI Lilly (LLY) › Free cash flow
ELI Lilly (LLY) free cash flow by quarter
ELI Lilly's free cash flow was $8.2B in Q3 2026 (third quarter 2026), +6% from Q2 2026. Over the last 7 quarters it ranged from $156M (Q1 2025) to $8.2B (Q3 2026).
| Quarter | Free cash flow | Q/Q | Y/Y |
|---|---|---|---|
| Q3 2026 | $8.2B | +6% | +22% |
| Q2 2026 | $7.8B | +158% | +458% |
| Q1 2026 | $3.0B | +344% | 19× |
| Q4 2025 | $678M | -90% | — |
| Q3 2025 | $6.7B | +385% | — |
| Q2 2025 | $1.4B | +791% | — |
| Q1 2025 | $156M | — | — |
Q3 2026 at a glance
ELI Lilly, Q3 2026: revenue $24.4B (+39% year over year), operating margin 34.5%, net earnings $6.5B, operating cash flow $11.4B. The chart follows the revenue to costs, profit and cash.
Questions
What is ELI Lilly's free cash flow?
ELI Lilly's free cash flow was $8.2B in Q3 2026 (third quarter 2026), +6% from Q2 2026.
How has ELI Lilly's free cash flow changed?
Over the last 7 quarters it ranged from $156M (Q1 2025) to $8.2B (Q3 2026).